PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 38 filers reported holding PROTARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,456 | -37.9% | 27,818 | -11.2% | 0.00% | – |
| Q2 2023 | $74,850 | -24.4% | 31,318 | -0.9% | 0.00% | – |
| Q1 2023 | $98,964 | -21.8% | 31,618 | -33.0% | 0.00% | – |
| Q4 2022 | $126,544 | -18.4% | 47,218 | -9.9% | 0.00% | – |
| Q3 2022 | $155,000 | -0.6% | 52,418 | -1.3% | 0.00% | – |
| Q2 2022 | $156,000 | -53.7% | 53,118 | -19.4% | 0.00% | -100.0% |
| Q1 2022 | $337,000 | -70.8% | 65,918 | -61.4% | 0.00% | -66.7% |
| Q4 2021 | $1,154,000 | -1.2% | 170,918 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $1,168,000 | +105.6% | 168,818 | +189.5% | 0.00% | +200.0% |
| Q2 2021 | $568,000 | +197.4% | 58,318 | +381.3% | 0.00% | 0.0% |
| Q1 2021 | $191,000 | -59.6% | 12,118 | -37.9% | 0.00% | 0.0% |
| Q4 2020 | $473,000 | – | 19,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $43,059,000 | 8.42% |
| CVI Holdings, LLC | 168,836 | $2,842,000 | 1.16% |
| Soleus Capital Management, L.P. | 100,000 | $1,683,000 | 0.89% |
| Ikarian Capital, LLC | 722,443 | $12,158,000 | 0.88% |
| COWEN AND COMPANY, LLC | 124,171 | $2,090,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 782,670 | $13,172,000 | 0.32% |
| Cormorant Asset Management, LP | 450,000 | $7,574,000 | 0.29% |
| Rock Springs Capital Management LP | 643,622 | $10,832,000 | 0.28% |
| Perceptive Advisors | 608,544 | $10,242,000 | 0.15% |
| Maven Securities LTD | 100,000 | $1,688,000 | 0.14% |